Calidi Biotherapeutics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Calidi Biotherapeutics, Inc. (CLDI) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$465.13 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2022-05-11
- Calidi Biotherapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2022-03-31 was -$465.13K.
- Calidi Biotherapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-12-31 was -$134.69K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2022-03-31 | -$465.13K 10-Q · filed 2022-05-11 | -$599.82K derived: sum of 2 quarters · filed 2022-05-11 | |
| 2021-12-31 | -$134.69K derived: 10-K 9 month − 10-Q 6 month · filed 2022-03-31 | $1.06M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $1.20M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |